Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.58 |
| ▸ | CA6 | P23280 | 5/20 | 0.58 |
| ▸ | CA7 | P43166 | 5/20 | 0.58 |
| ▸ | CA9 | Q16790 | 5/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.58 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.58 |
| ▸ | CA2 | P00918 | 4/20 | 0.58 |
| ▸ | CA4 | P22748 | 4/20 | 0.58 |
| ▸ | CA5A | P35218 | 4/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | CA3 | P07451 | 3/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | RECQL | P46063 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19257448 | 1.00 | CA12 (0.58) | CA12CA6CA7CA9CA14 | |
| SCHEMBL757066 | 1.00 | CA12 (0.58) | CA12CA6CA7CA9CA14 | |
| SCHEMBL4908680 | 1.00 | CA12 (0.58) | CA12CA6CA7CA9CA14 | |
| SCHEMBL19257457 | 1.00 | CA12 (0.58) | CA12CA6CA7CA9CA14 | |
| SCHEMBL24001448 | 0.90 | CA12 (0.52) | CA12CA6CA7CA9CA14 | |
| SCHEMBL4746164 | 0.86 | LMNA (0.32) | CA12CA6CA7CA9CA14 | |
| SCHEMBL4745076 | 0.86 | LMNA (0.32) | CA12CA6CA7CA9CA14 | |
| SCHEMBL17766691 | 0.86 | LMNA (0.32) | CA12CA6CA7CA9CA14 | |
| SCHEMBL4745112 | 0.86 | LMNA (0.32) | CA12CA6CA7CA9CA14 | |
| SCHEMBL17766693 | 0.86 | LMNA (0.32) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1914254-B1 | Crosslinkers for improving stability of polyurethane foams | EVONIK DEGUSSA GMBH (DE) | 2017-08-23 | — | — | EP | claimed |
| EP-1914254-A1 | Crosslinkers for improving stability of polyurethane foams | Air Products and Chemicals, Inc. (US) | 2008-04-23 | — | — | EP | claimed |
| US-20080090922-A1 | Crosslinkers for improving stability of polyurethane foams | EVONIK OPERATIONS GMBH (DE) | 2008-04-17 | — | — | US | claimed |
| US-11696953-B2 | Poly(beta-amino esters) and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-07-11 | — | — | US | disclosed |
| US-11696953-B2 | Poly(beta-amino esters) and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-07-11 | — | — | US | disclosed |
| US-11073451-B2 | Biocompatible method of functionalising substrates with inert surfaces | KODE BIOTECH LIMITED (NZ) | 2021-07-27 | — | — | US | disclosed |
| US-20190230931-A1 | SURFACE TREATMENTS | BOVIN NICOLAI VLADIMIROVICH (RU) | 2019-08-01 | — | — | US | disclosed |
| US-20190195759-A1 | BIOCOMPATIBLE METHOD OF FUNCTIONALISING SUBSTRATES WITH INERT SURFACES | KODE BIOTECH LIMITED (NZ) | 2019-06-27 | — | — | US | disclosed |
| EP-1914254-B1 | Crosslinkers for improving stability of polyurethane foams | EVONIK DEGUSSA GMBH (DE) | 2017-08-23 | — | — | EP | disclosed |
| US-20170231228-A1 | SURFACE TREATMENTS | BOVIN NICOLAI VLADIMIROVICH (RU) | 2017-08-17 | — | — | US | disclosed |
| WO-2016072863-A1 | ANTIMICROBIAL SURFACE TREATMENT | BOVIN NICOLAI VLADIMIROVICH (RU) | 2016-05-12 | — | — | WO | disclosed |
| US-8552078-B2 | Non-fugitive tertiary amine catalyst and alkylated polyamine crosslinking additives; aging resistance | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2013-10-08 | — | — | US | disclosed |
| EP-1914254-A1 | Crosslinkers for improving stability of polyurethane foams | Air Products and Chemicals, Inc. (US) | 2008-04-23 | — | — | EP | disclosed |
| US-20080090922-A1 | Crosslinkers for improving stability of polyurethane foams | EVONIK OPERATIONS GMBH (DE) | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190230931-A1 | SURFACE TREATMENTS | PHOSPHO1, SGMS2, SGMS1 | CA12 3782/4885CA6 4222/4885CA7 3947/4885 |
| US-11696953-B2 | Poly(beta-amino esters) and uses thereof | BCAT1, BCAT2, SNRPE | CA12 2268/4885CA6 2620/4885CA7 3039/4885 |
| US-20170231228-A1 | SURFACE TREATMENTS | PHOSPHO1, SGMS2, SGMS1 | CA12 3782/4885CA6 4222/4885CA7 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.